Results 11 to 20 of about 3,196,781 (312)

Human Proteome Microarray identifies autoantibodies to tumor‐associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma

open access: yesMolecular Oncology, 2023
The identification of the high‐efficiency and non‐invasive biomarkers for hepatocellular carcinoma (HCC) detection is urgently needed. This study aims to screen out potential autoantibodies to tumor‐associated antigens (TAAbs) and to assess their ...
Qian Yang   +9 more
doaj   +1 more source

Adenocarcinosarcoma at the esophagogastric junction with long esophageal invasion: a case report

open access: yesSurgical Case Reports, 2020
Background Carcinosarcoma of the esophagus or esophagogastric junction (EGJ) is a rare malignancy with both carcinomatous and sarcomatous components.
Kenichiro Furukawa   +4 more
doaj   +1 more source

HIV infection and domestic smoke exposure, but not human papillomavirus, are risk factors for esophageal squamous cell carcinoma in Zambia: a case-control study [PDF]

open access: yes, 2015
(c) 2015 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original ...
Asombang, AW   +23 more
core   +1 more source

Esophageal Squamous Cell Cancer: Pathogenesis and Epidemiology

open access: yes, 2023
Esophageal cancer is a highly lethal disease. Despite an increasing incidence of adenocarcinoma in last decades, squamous cell carcinoma remains the predominant cell type worldwide. The majority of squamous cell cancers are from the East.
Law, S, Wong, C
core   +1 more source

Non-occlusive mesenteric ischemia associated with enteral feeding after esophagectomy for esophageal cancer: report of two cases and review of the literature

open access: yesSurgical Case Reports, 2019
Background Non-occlusive mesenteric ischemia (NOMI) is a rare but life-threatening complication of early postoperative enteral feeding. We herein report two patients who developed NOMI during enteral feeding after esophagectomy. Case presentation In case
Daisuke Kurita   +5 more
doaj   +1 more source

Long-term effect of hospital volume on the postoperative prognosis of 158,618 patients with esophageal squamous cell carcinoma in China

open access: yesFrontiers in Oncology, 2023
BackgroundThe impact of hospital volume on the long-term survival of esophageal squamous cell carcinoma (ESCC) has not been well assessed in China, especially for stage I–III stage ESCC.
Ling-Ling Lei   +26 more
doaj   +1 more source

Viruses and esophageal cancer [PDF]

open access: yesDiseases of the Esophagus, 2020
Summary Esophageal adenocarcinoma (EAC) has had the fastest increasing incidence of any solid tumor in the United States in the last 30 years. Long standing gastroesophageal reflux disease is a well-established risk factor with strong associations with obesity, alcohol and tobacco.
Carolyn, Chang, Stephanie G, Worrell
openaire   +2 more sources

Clinical significance of VEGF-A, -C and -D expression in esophageal malignancies [PDF]

open access: yes, 2005
Vascular endothelial growth factors ( VEGF)- A, - C and - D are members of the proangiogenic VEGF family of glycoproteins. VEGF-A is known to be the most important angiogenic factor under physiological and pathological conditions, while VEGF-C and VEGF-D
Jauch, Karl-Walter   +2 more
core   +1 more source

Esophageal cancer

open access: yesCurrent Opinion in Gastroenterology, 1999
Carcinoma of the esophagus and gastroesophageal junction continues to be an aggressive cancer with poor prognosis, despite improved surgical results and the potential benefit of combined multimodality regimens. Additional data seem to confirm the rising incidence of adenocarcinoma, although users of nonsteroidal anti-inflammatory drugs seem to have a ...
T, Lerut, G, Decker
openaire   +4 more sources

Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial

open access: yesNature Communications, 2021
The benefit of induction chemotherapy before definitive chemoradiotherapy (CRT) for patients with esophageal cancer is still uncertain. The results of this phase II randomized trial show that the addition of induction chemotherapy to CRT does not improve
Shiliang Liu   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy